We are live on ! Find out more
IART icon

Integra LifeSciences

143 hedge funds and large institutions have $2.06B invested in Integra LifeSciences in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more call options, than puts

Call options by funds: $719K | Put options by funds: $382K

66% more capital invested

Capital invested by funds: $1.24B → $2.06B (+$815M)

20% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 45

3% less funds holding

Funds holding: 147143 (-4)

12% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 17

Holders
143
Holders Change
-4
Holders Change %
-2.72%
% of All Funds
4.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
54
Reduced
45
Closed
17
Calls
$719K
Puts
$382K
Net Calls
+$337K
Net Calls Change
+$256K
Name Holding Trade Value Shares
Change
Change in
Stake
PA
151
Profund Advisors
Maryland
-$250K -13,013 Closed
B
152
Baird
Wisconsin
-$208K -10,826 Closed
Jane Street
153
Jane Street
New York
-$201K -10,446 Closed
ARC
154
Absolute Return Capital
Massachusetts
-$184K -9,546 Closed
Federated Hermes
155
Federated Hermes
Pennsylvania
-$101K -5,238 Closed
VFA
156
Virtus Fund Advisers
Connecticut
-$100K -5,213 Closed
ACS
157
Archford Capital Strategies
Illinois
-$7.62K -396 Closed
Envestnet Asset Management
158
Envestnet Asset Management
Illinois
-$4K -201 Closed
BRWA
159
B. Riley Wealth Advisors
Florida
-$3.06K -159 Closed

IART Hedge Fund Activity: Q3 2014 in Review

143 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2014, worth a combined $2.06B — up 66% from $1.24B a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of IART and 15 opened new positions — a net loss of 2 holders — while 45 trimmed existing stakes and 54 added.

The largest buyer was Westwood Holdings Group, opening a new position worth an estimated $37.3M. The largest seller was Boston Partners, cutting an estimated $29.3M.

  • 143 institutional investors held Integra LifeSciences (IART) as of Q3 2014, down from 147 in Q2 2014.
  • Funds reported $2.06B of Integra LifeSciences stock for Q3 2014, up 66% quarter-over-quarter.
  • 15 funds opened new Integra LifeSciences positions in Q3 2014 and 17 closed out, a net change of -2 holders.
  • The largest Integra LifeSciences buyer in Q3 2014 was Westwood Holdings Group, an estimated $37.3M added.
  • The largest Integra LifeSciences seller in Q3 2014 was Boston Partners, an estimated $29.3M sold.

Based on aggregated 13F filings for Q3 2014.